Aptamers – The rising realm amongst stakeholders i..

created a new article

3 yrs

Aptamers – The rising realm amongst stakeholders in pursuit of alternative therapies to antibodies therapies | #aptamer # aptamers-based therapeutics # aptamer-based therapies # aptamer technologies # Market Insights # Market Research

Aptamers – The rising realm amongst stakeholders in pursuit of alternative therapies to antibodies therapies

Aptamers have gained a lot of momentum in the past decade. It is worth highlighting that in 2005, Macugen became the first and the only USFDA approved aptamer drug for treating age-related macular degeneration (AMD).

Comment

3 yrs

Aptamers – The rising realm amongst stakeholders in pursuit of alternative therapies to antibodies therapies

Language